Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
NEW YORK and NEW ORLEANS, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with...
-
PHILADELPHIA, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (NASDAQ: CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ: CYTK). The...
-
Synopsys, Inc. Hit with Securities Fraud Class Action after IP Underperformance – Contact BFA Law if You Suffered Losses
-
SAN FRANCISCO, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Girard Sharp LLP, a national investment, securities, and consumer class action firm, is investigating potential securities claims on behalf of former...
-
The complaint alleges Synopsys hid AI-driven Design IP margin deterioration, negative financial impacts, and misleading statements, leading to a stock drop
-
SNPS Investors Have Opportunity to Lead Synopsys, Inc. Securities Fraud Lawsuit with the Schall Law Firm
-
Synopsys Shareholder Lawsuit Filed - Contact Bernstein Liebhard For More Information
-
PHILADELPHIA, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (NASDAQ: CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ: CYTK). The...
-
Lose Money on Synopsys, Inc.? Contact BFA Law before December 30 Securities Class Action Deadline
-
Synopsys, Inc. (SNPS) Investors are Encouraged to Act before the Upcoming December 30 Securities Fraud Deadline – Contact BFA Law if You Lost Money